| 摘要 |
<p>The invention relates to a composition for controlling the evolution of multiple sclerosis. The inventive composition is characterised in that it comprises at least: one conjugate between Poly-Lysine and at least one fatty acid, and one conjugate between Poly-Lysine and at least one antioxidant, and one conjugate between Poly-Lysine and at least one amino acid derivative.</p> |
